Hidenori Ojima

24.9k total citations · 3 hit papers
124 papers, 6.0k citations indexed

About

Hidenori Ojima is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Hidenori Ojima has authored 124 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Surgery, 55 papers in Oncology and 37 papers in Molecular Biology. Recurrent topics in Hidenori Ojima's work include Cholangiocarcinoma and Gallbladder Cancer Studies (49 papers), Pancreatic and Hepatic Oncology Research (29 papers) and Gallbladder and Bile Duct Disorders (23 papers). Hidenori Ojima is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (49 papers), Pancreatic and Hepatic Oncology Research (29 papers) and Gallbladder and Bile Duct Disorders (23 papers). Hidenori Ojima collaborates with scholars based in Japan, United Kingdom and United States. Hidenori Ojima's co-authors include Tomoo Kosuge, Tatsuhiro Shibata, Kazuaki Shimada, Nobuyoshi Hiraoka, Yae Kanai, Setsuo Hirohashi, Yoshihiro Sakamoto, Akiko Kokubu, Tsuyoshi Sano and Takuji Okusaka and has published in prestigious journals such as Nature Genetics, Gastroenterology and PLoS ONE.

In The Last Decade

Hidenori Ojima

120 papers receiving 5.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic spectra of biliary tract cancer

2015 853 citations Yasuhito Arai, Tomoki Shirota et al. profile →
Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma

2013 400 citations Yasuhito Arai, Tomoki Shirota et al. profile →
Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification

2018 333 citations Yutaka Kurebayashi, Hidenori Ojima et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hidenori Ojima Japan	38	2.9k	2.6k	2.0k	1.5k	1.2k	124	6.0k
Shingi Imaoka Japan	37	2.1k 0.7×	2.2k 0.8×	1.6k 0.8×	1.7k 1.1×	894 0.8×	190	5.9k
Jun Akiba Japan	40	1.0k 0.4×	1.7k 0.7×	1.3k 0.6×	963 0.6×	929 0.8×	309	5.5k
Alan Anthoney United Kingdom	28	3.9k 1.4×	3.9k 1.5×	1.5k 0.8×	2.6k 1.7×	1.0k 0.9×	108	6.6k
Zhao‐Chong Zeng China	37	1.1k 0.4×	1.5k 0.6×	2.2k 1.1×	1.2k 0.8×	1.4k 1.2×	198	5.1k
Shinichi Aishima Japan	40	2.1k 0.7×	2.2k 0.8×	990 0.5×	912 0.6×	1.1k 0.9×	167	5.1k
Yasushi Ichikawa Japan	43	1.3k 0.5×	2.4k 0.9×	1.4k 0.7×	1.0k 0.7×	1.0k 0.9×	247	5.0k
Kazuhiro Mizumoto Japan	52	2.4k 0.8×	4.7k 1.8×	3.5k 1.7×	1.2k 0.8×	2.3k 1.9×	221	8.1k
Shinichi Yachida Japan	38	1.6k 0.5×	4.6k 1.8×	2.1k 1.1×	1.6k 1.0×	2.4k 2.0×	141	6.9k
Gabrielle Couchy France	32	1.0k 0.4×	1.4k 0.5×	3.0k 1.5×	1.1k 0.7×	2.1k 1.8×	64	6.1k
Jianping Xiong China	36	772 0.3×	2.0k 0.8×	2.1k 1.0×	1.6k 1.1×	1.3k 1.1×	189	5.0k

Countries citing papers authored by Hidenori Ojima

Since Specialization

Citations

This map shows the geographic impact of Hidenori Ojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidenori Ojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidenori Ojima more than expected).

Fields of papers citing papers by Hidenori Ojima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidenori Ojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidenori Ojima. The network helps show where Hidenori Ojima may publish in the future.

Co-authorship network of co-authors of Hidenori Ojima

This figure shows the co-authorship network connecting the top 25 collaborators of Hidenori Ojima. A scholar is included among the top collaborators of Hidenori Ojima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidenori Ojima. Hidenori Ojima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kurebayashi, Yutaka, Katsutoshi Sugimoto, Hanako Tsujikawa, et al.. (2024). Spatial Dynamics of T- and B-Cell Responses Predicts Clinical Outcome of Resectable and Unresectable Hepatocellular Carcinoma. Clinical Cancer Research. 30(24). 5666–5680. 7 indexed citations

Itano, Osamu, Minoru Kitago, Yuta Abe, et al.. (2023). Surgical and Oncological Outcomes of Salvage Hepatectomy for Locally Recurrent Hepatocellular Carcinoma after Locoregional Therapy: A Single-Institution Experience. Cancers. 15(8). 2320–2320. 2 indexed citations

Abe, Yuta, Osamu Itano, Hidenori Ojima, et al.. (2023). Phase I study of neoadjuvant S‐1 plus cisplatin with concurrent radiation for biliary tract cancer (Tokyo Study Group for Biliary Cancer: TOSBIC02). Annals of Gastroenterological Surgery. 7(5). 808–818. 2 indexed citations

Tian, Ying, Mao Fujimoto, Hidenori Ojima, et al.. (2023). DNA methylation alterations of ADCY5, MICAL2, and PLEKHG2 during the developmental stage of cryptogenic hepatocellular carcinoma. Hepatology Research. 54(3). 284–299. 3 indexed citations

Sakamoto, Yasunari, et al.. (2019). Synergistic and Pharmacotherapeutic Effects of Gemcitabine and Cisplatin Combined Administration on Biliary Tract Cancer Cell Lines. Cells. 8(9). 1026–1026. 4 indexed citations

Bolatkan, Amina, Syuzo Kaneko, Noriko Ikawa, et al.. (2019). Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma. Biomolecules. 9(12). 810–810. 22 indexed citations

Ojima, Hidenori, Yohei Masugi, Hanako Tsujikawa, et al.. (2018). Steatotic and nonsteatotic scirrhous hepatocellular carcinomas reveal distinct clinicopathological features. Human Pathology. 86. 222–232. 17 indexed citations

Fujii‐Nishimura, Yoko, Ken Yamazaki, Yohei Masugi, et al.. (2018). Mesenchymal–epithelial transition of pancreatic cancer cells at perineural invasion sites is induced by Schwann cells. Pathology International. 68(4). 214–223. 27 indexed citations

Takizawa, Tsubasa, Junki Maehara, Koichi Oki, et al.. (2017). Serial changes of corticospinal tract hyperintensity on magnetic resonance imaging from the preclinical stage in amyotrophic lateral sclerosis. Neurology and Clinical Neuroscience. 6(1). 29–30. 1 indexed citations

10.

Sakamoto, Akihisa, Shinjiro Hino, Katsuya Nagaoka, et al.. (2015). Lysine Demethylase LSD1 Coordinates Glycolytic and Mitochondrial Metabolism in Hepatocellular Carcinoma Cells. Cancer Research. 75(7). 1445–1456. 77 indexed citations

11.

Shirota, Tomoki, Hidenori Ojima, Nobuyoshi Hiraoka, et al.. (2015). Heat Shock Protein 90 Is a Potential Therapeutic Target in Cholangiocarcinoma. Molecular Cancer Therapeutics. 14(9). 1985–1993. 25 indexed citations

12.

Yoshikawa, Noritada, Noriaki Shimizu, Hidenori Ojima, et al.. (2014). Down-regulation of hypoxia-inducible factor-1 alpha and vascular endothelial growth factor by HEXIM1 attenuates myocardial angiogenesis in hypoxic mice. Biochemical and Biophysical Research Communications. 453(3). 600–605. 5 indexed citations

13.

Ojima, Hidenori. (2012). Clinicopathological significance of growth factors and their receptors as potential therapeutic targets for biliary tract carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences. 19(4). 319–325. 1 indexed citations

14.

Nara, Satoshi, Kazuaki Shimada, Yoshihiro Sakamoto, et al.. (2012). Prognostic impact of marginal resection for patients with solitary hepatocellular carcinoma: Evidence from 570 hepatectomies. Surgery. 151(4). 526–536. 44 indexed citations

15.

Nara, Satoshi, Hidenori Ojima, Yoji Kishi, et al.. (2012). A Case of Intrahepatic Cholangiocarcinoma with The Left Portal Vein Tumor Thrombus (Vp3) Containing a Sarcomatous Component. The Japanese Journal of Gastroenterological Surgery. 45(7). 732–739.

16.

Satow, Reiko, Miki Shitashige, Yae Kanai, et al.. (2010). Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma. Clinical Cancer Research. 16(9). 2518–2528. 138 indexed citations

17.

Saito, Shigeru, Hidenori Ojima, Hitoshi Ichikawa, Setsuo Hirohashi, & Tadashi Kondo. (2008). Molecular background of α‐fetoprotein in liver cancer cells as revealed by global RNA expression analysis. Cancer Science. 99(12). 2402–2409. 31 indexed citations

18.

Ojima, Hidenori, Yae Kanai, Motoki Iwasaki, et al.. (2008). Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Science. 100(1). 62–70. 26 indexed citations

19.

Katoh, Hiroto, Tatsuhiro Shibata, Akiko Kokubu, et al.. (2006). Genetic inactivation of the APC gene contributes to the malignant progression of sporadic hepatocellular carcinoma: A case report. Genes Chromosomes and Cancer. 45(11). 1050–1057. 14 indexed citations

20.

Esaki, Minoru, Kazuaki Shimada, Tsuyoshi Sano, et al.. (2005). Surgical results for hepatocellular carcinoma with bile duct invasion: A clinicopathologic comparison between macroscopic and microscopic tumor thrombus. Journal of Surgical Oncology. 90(4). 226–232. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact